Emami Q4 FY26 Results: Revenue Declines 4% to ₹925 Crore Amidst Challenging Summer
Emami Limited reported Q4 FY26 consolidated revenue of ₹925 crore, down 4%, impacted by a weak summer season. Core business ex-summer portfolio grew 11%. Gross margins improved to 68.4%. The company is confident for FY27, expecting double-digit growth in summer brands and strategic investments.
The revenue decline and profit drop due to seasonal factors and external disruptions have a moderate impact. However, the underlying strength of the core business, margin expansion, and strategic focus on growth categories and investments suggest potential for recovery and future growth, tempering the impact.
The results show a decline in revenue and profit due to seasonal factors and geopolitical issues, which is negative. However, the company highlights resilience in its core business, margin improvement, and strategic growth initiatives, which are positive. Overall, the sentiment is neutral due to the mixed performance.
Emami Limited held an investor conference call on May 21, 2026, to discuss its audited financial results for the quarter and financial year ended March 31, 2026. The company reported consolidated revenues of ₹925 crore for Q4 FY26, a 4% decline compared to the previous year. This decrease was primarily attributed to a weak summer season, which impacted demand for talcum powders significantly, with that segment declining by 22% and talcum powders alone falling by 40%.
Despite the overall revenue dip, the company highlighted positive performance in other segments. The domestic business, excluding the summer portfolio, showed resilience with 11% growth. Specific brands like Kesh King grew by 14%, the Healthcare range by 7%, strategic investments by 34%, and 7 Oils in One also by 34%. Boroplus, excluding talc, grew by 4%.
Financially, gross margins expanded by 250 basis points to 68.4% in Q4 FY26, driven by cost discipline and pricing actions. EBITDA stood at ₹187 crore, a 15% decline, while Profit After Tax (PAT) was ₹143 crore, a 12% decrease. For the full year FY26, revenues were ₹3,780 crore (a 1% decline), with gross margins at 69.9% (up 130 basis points), EBITDA at ₹964 crore (down 6%), and PAT at ₹775 crore (down 4%).
The company also discussed its strategic investments, including The Man Company and Brillare, aiming for sustained growth. Acquisitions like Axiom (fruit juice category) and IncNut (Vedix and SkinKraft for personalized beauty) were highlighted as value-accretive additions with significant growth potential. The international business saw a 5% decline in the quarter due to geopolitical disruptions in the Middle East affecting supply chains and increasing freight costs. However, the company anticipates stabilization and double-digit growth from the second quarter of FY27.
Management expressed confidence for FY27, expecting strong double-digit growth in summer brands like Navratna and Dermicool, despite a challenging start to the season. They are focused on strengthening core brands, enhancing omnichannel capabilities, and continued innovation. The company also noted a conscious reduction of receivables by over ₹100 crore, improving the working capital cycle.
What to do with a filing like this
Emami Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Emami Limited. Read the original for the full detail.